Recombinant Abelson Tyrosine Protein Kinase (rAbl) Regulates Various Functions of Buffalo Peripheral Blood Mononuclear Cells.

Animals (Basel)

Guangxi Colleges and Universities Key Laboratory of Prevention and Control for Animal Disease, College of Animal Science and Technology, Guangxi University, Nanning 530005, China.

Published: January 2025

can modulate host immune mechanisms through excretory-secretory products (ESP). As one of the components of ESP, it is unknown whether Abelson tyrosine protein kinase (Abl) is involved in parasite-host immune interaction. To investigate the immunoregulatory function of Abl in , we cloned and expressed the gigantica Abl protein and assessed its effect on specific immune functions of buffalo peripheral blood mononuclear cells (PBMCs). Recombinant Abelson tyrosine protein kinase (rAbl) was expressed in . Western blot analysis was performed to assess the reactivity of anti-rAbl antibodies with rAbl, serum from -infected buffalo, and excretion and secretion products of . Immunohistochemical analysis was conducted to determine the localization of Abl in tissues from larval stages and adult worms of . Furthermore, immunofluorescence analysis was utilized to evaluate the binding ability of the rAbl protein to buffalo peripheral blood mononuclear cells (PBMCs), as well as to investigate the effects of varying concentrations of rAbl protein (5, 10, 20, 40, and 80 μg/mL) on the functional responses of PBMCs. Anti-rAbl antibodies specifically recognize rAbl, serum from buffalo infected with , and ESP. rAbl is localized in the cecum and capsule of juvenile worms, as well as in the testis and viellaria of adult worms. Additionally, rAbl enhances cell proliferation, migration, nitric oxide (NO) production, and phagocytosis, while also increasing the transcription levels of cytokines (IFN-γ, IL-12, TNF-α, IL-4, IL-10, and TGF-β). The results indicate that rAbl can influence the immune function of PBMCs. Further investigation into the immunomodulatory properties of the rAbl protein will enhance our understanding of the immune interaction mechanisms between trematodes and their hosts.

Download full-text PDF

Source
http://dx.doi.org/10.3390/ani15020179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758316PMC

Publication Analysis

Top Keywords

abelson tyrosine
12
tyrosine protein
12
protein kinase
12
buffalo peripheral
12
peripheral blood
12
blood mononuclear
12
mononuclear cells
12
rabl protein
12
rabl
10
recombinant abelson
8

Similar Publications

Recombinant Abelson Tyrosine Protein Kinase (rAbl) Regulates Various Functions of Buffalo Peripheral Blood Mononuclear Cells.

Animals (Basel)

January 2025

Guangxi Colleges and Universities Key Laboratory of Prevention and Control for Animal Disease, College of Animal Science and Technology, Guangxi University, Nanning 530005, China.

can modulate host immune mechanisms through excretory-secretory products (ESP). As one of the components of ESP, it is unknown whether Abelson tyrosine protein kinase (Abl) is involved in parasite-host immune interaction. To investigate the immunoregulatory function of Abl in , we cloned and expressed the gigantica Abl protein and assessed its effect on specific immune functions of buffalo peripheral blood mononuclear cells (PBMCs).

View Article and Find Full Text PDF

Background: Yes-associated protein 1 (YAP1) regulates the survival, proliferation, and stemness of cells, and contributes to the development of metabolic dysfunction associated fatty liver disease (MAFLD). However, the regulatory role of intestinal YAP1 in MAFLD still remains unclear.

Methods: Terminal ileal specimens were used to compare intestinal YAP1 activation in patients with and without MAFLD.

View Article and Find Full Text PDF

Febuxostat enhances the efficacy of dasatinib by inhibiting ATP-binding cassette subfamily G member 2 (ABCG2) in chronic myeloid leukemia cells.

Biomed Pharmacother

December 2024

Department of Pharmacy, Osaka University Hospital, Suita, Osaka 5650871, Japan; Department of Hospital Pharmacy, Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan.

Article Synopsis
  • - Dasatinib is a medication used to treat chronic myeloid leukemia (CML), but some patients develop resistance due to high levels of the ABCG2 protein in their cancer cells.
  • - A study involving 65 CML patients found that those taking the xanthine oxidase inhibitor febuxostat alongside dasatinib had better treatment outcomes, with significantly higher rates of early and major molecular response.
  • - Laboratory experiments showed that febuxostat can lower cell viability and increase dasatinib levels in CML cells, suggesting it helps enhance dasatinib's effects by reducing ABCG2's ability to eject the drug from cells, which may offer new ways to tackle TKI resistance in CML treatment. *
View Article and Find Full Text PDF
Article Synopsis
  • - Nilotinib is an FDA-approved drug for chronic myeloid leukemia that may have potential neuroprotective effects, leading researchers to investigate its use in treating Alzheimer's disease (AD) and Parkinson's disease (PD).
  • - The study examined nilotinib's impact on amyloid processing and mitochondrial function in SH-SY5Y neuroblastoma cells, finding no significant changes in key gene expressions related to amyloid-β processing or neuronal health.
  • - While BACE1 and ADAM10 proteins were increased at certain nilotinib concentrations, overall results suggest that nilotinib does not effectively provide neuroprotection.
View Article and Find Full Text PDF

Background: Tyrosine kinase inhibitors improve chronic myeloid leukemia (CML) outcomes. Dasatinib inhibits breakpoint cluster region-Abelson 1 proto-oncogene tyrosine kinase better than imatinib in CML. T-regulatory cells prevent autoimmune diseases and aberrant immune responses by reducing oncoprotein antigen reactivity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!